Pentosan polysulfate sodium and retinal safety: reconciling conflicting evidence and defining a pragmatic clinical pharmacology framework.
Ingawale Shwetambari, Khan Hira Bakhtiar, Nadeem Mehwash·Expert review of clinical pharmacology
INTRODUCTION: Pentosan polysulfate sodium (PPS) remains an oral treatment option for selected patients with bladder pain syndrome, but recognition of PPS-associated pigmentary maculopathy has created uncertainty about long-term prescribing. The central clinical problem is that reported retinal-risk estimates vary marke…